RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
This Quarter Return
+9.94%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$928M
AUM Growth
+$928M
(+1.6%)
Cap. Flow
-$37.6M
Cap. Flow
% of AUM
-4.05%
Top 10 Holdings %
Top 10 Hldgs %
57.36%
Holding
71
New
15
Increased
6
Reduced
13
Closed
13
Top Buys
| 1 |
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
|
$102M |
| 2 |
Collegium Pharmaceutical
COLL
|
$27.6M |
| 3 |
Ardelyx
ARDX
|
$27.5M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
$23.3M |
| 5 |
MDCO
Medicines Co
MDCO
|
$20.2M |
Top Sells
| 1 |
BioCryst Pharmaceuticals
BCRX
|
$64.5M |
| 2 |
Arbutus Biopharma
ABUS
|
$47.4M |
| 3 |
Dynavax Technologies
DVAX
|
$43M |
| 4 |
DYAX
DYAX CORPORATION
DYAX
|
$39.9M |
| 5 |
Larimar Therapeutics
LRMR
|
$29M |
Sector Composition
| 1 | Healthcare | 81.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SIOX
1
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $102M | 10.25% | +5,000,000 | New | +$102M |
|
|
ACHN
2
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $88.1M | 8.86% | 9,945,997 +1,738,467 | +21% | +$15.4M |
|
|
DYAX
3
DELISTED
DYAX CORPORATION
DYAX
| $71.6M | 7.21% | 2,703,093 -1,504,501 | -36% | -$39.9M |
|
4
TG Therapeutics
TGTX
$4.65B
| $54.8M | 5.51% | 3,302,213 +177,064 | +6% | +$2.94M |
|
|
RGLS
5
DELISTED
Regulus Therapeutics
RGLS
| $41.5M | 4.18% | 3,790,476 +199,788 | +6% | +$2.19M |
|
6
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $39.9M | 4.01% | 1,380,320 -175,035 | -11% | -$5.06M |
|
|
7
BioCryst Pharmaceuticals
BCRX
$1.74B
| $38.9M | 3.91% | 2,605,361 -4,321,256 | -62% | -$64.5M |
|
|
DRNA
8
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $33.9M | 3.41% | 2,428,571 | – | – |
|
9
Ascendis Pharma
ASND
$11.8B
| $33.8M | 3.4% | 1,913,153 +889,501 | +87% | +$15.7M |
|
|
10
Collegium Pharmaceutical
COLL
$1.22B
| $27.6M | 2.77% | +1,545,410 | New | +$27.6M |
|
|
11
Ardelyx
ARDX
$1.53B
| $27.5M | 2.76% | +1,719,945 | New | +$27.5M |
|
12
Protara Therapeutics
TARA
$120M
| $26.9M | 2.71% | 1,506,872 +256,872 | +21% | +$4.59M |
|
13
Xencor
XNCR
$580M
| $23.6M | 2.38% | 1,075,410 -1,074,013 | -50% | -$23.6M |
|
|
BPMC
14
DELISTED
Blueprint Medicines
BPMC
| $23.3M | 2.34% | +878,348 | New | +$23.3M |
|
|
BLCM
15
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $21.8M | 2.2% | 1,026,402 | – | – |
|
|
MDCO
16
DELISTED
Medicines Co
MDCO
| $20.2M | 2.03% | +705,925 | New | +$20.2M |
|
|
BLUE
17
DELISTED
bluebird bio
BLUE
| $18.4M | 1.85% | 109,383 -90,996 | -45% | -$15.3M |
|
|
18
Dynavax Technologies
DVAX
$1.19B
| $17.9M | 1.81% | 766,000 -1,834,000 | -71% | -$43M |
|
19
Cidara Therapeutics
CDTX
$1.66B
| $16M | 1.61% | +1,141,333 | New | +$16M |
|
20
Novavax
NVAX
$1.21B
| $15.9M | 1.6% | 1,431,232 | – | – |
|
|
JUNO
21
DELISTED
Juno Therapeutics, Inc.
JUNO
| $14.9M | 1.5% | 280,000 | – | – |
|
|
AGEN
22
Agenus
AGEN
$133M
| $13.8M | 1.39% | +1,600,000 | New | +$13.8M |
|
23
Sangamo Therapeutics
SGMO
$157M
| $13.5M | 1.36% | 1,220,209 | – | – |
|
24
Omeros
OMER
$283M
| $13.5M | 1.36% | 749,000 | – | – |
|
25
TherapeuticsMD
TXMD
$12.8M
| $13.2M | 1.33% | 1,680,395 | – | – |
|